3 months ago
LLY
AnalystsRobyn KarnauskasRobyn Karnauskas's Stock Forecasts
AnalystsRobyn Karnauskas
Analyst Ranking
Bottom 4%
#4391 out of 4563 analysts
Average Return
-4.31%
Win Rate
43%58 out of 135
Risk vs Reward
Poor
Good
Robyn Karnauskas's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-09 - 2024-02-23 | Strong Buy |
Immunovant IncIMVT | +192.80% | $16.94 | $49.60 | 2020-01-09 - 2021-01-08 | Strong Buy |
Absci CorpABSI | +183.13% | $1.60 | $4.53 | 2023-08-15 - 2024-04-24 | Strong Buy |
Kodiak Sciences IncKOD | +116.19% | $69.35 | $149.93 | 2020-02-05 - 2021-02-05 | Strong Buy |
Arcus Biosciences IncRCUS | +106.37% | $13.97 | $28.83 | 2020-03-31 - 2021-04-01 | Strong Buy |
Robyn Karnauskas Analyst Color
Get additional color on Robyn Karnauskas's coverage of popular stocks
4 months ago
PFE
6 months ago
PFE
9 months ago
LLY
a year ago
MRK
Robyn Karnauskas's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amgen IncAMGN | 7 | Strong Buy | $320.00 | +17.21% | Reiterates | 13 days ago |
Regeneron Pharmaceuticals IncREGN | 14 | Strong Buy | $1,135.00 | +25.20% | Maintains | 22 days ago |
Biomea Fusion IncBMEA | 2 | Strong Buy | $55.00 | +410.68% | Reiterates | 24 days ago |
Merck & Co IncMRK | 7 | Strong Buy | $142.00 | +11.81% | Reiterates | a month ago |
Omniab IncOABI | 2 | Strong Buy | $10.00 | +119.30% | Maintains | a month ago |
Absci CorpABSI | 4 | Strong Buy | $9.00 | +98.68% | Maintains | a month ago |
Tourmaline Bio IncTRML | 2 | Strong Buy | $74.00 | +380.21% | Reiterates | a month ago |
Roivant Sciences LtdROIV | 5 | Strong Buy | $23.00 | +111.01% | Reiterates | a month ago |
Immunovant IncIMVT | 5 | Strong Buy | $48.00 | +66.67% | Reiterates | a month ago |
Biogen IncBIIB | 12 | Strong Buy | $340.00 | +68.33% | Reiterates | a month ago |
Arcus Biosciences IncRCUS | 5 | Strong Buy | $50.00 | +224.04% | Reiterates | a month ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $850.00 | +16.09% | Reiterates | a month ago |
Gilead Sciences IncGILD | 9 | Hold | $82.00 | +22.24% | Downgrades | 2 months ago |
Abbvie IncABBV | 7 | Strong Buy | $195.00 | +16.21% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 10 | Strong Buy | $508.00 | +26.76% | Maintains | 3 months ago |
Coherus Biosciences IncCHRS | 10 | Strong Buy | $8.00 | +296.04% | Maintains | 3 months ago |
Pfizer IncPFE | 5 | Strong Buy | $36.00 | +37.04% | Maintains | 4 months ago |
Curis IncCRIS | 1 | Strong Buy | $26.00 | +76.03% | Initiates Coverage On | 5 months ago |
Rayzebio IncRYZB | 1 | Strong Buy | $29.00 | -53.59% | Initiates Coverage On | 7 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $84.00 | +71.92% | Reiterates | 7 months ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $25.00 | -0.83% | Downgrades | 7 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $140.00 | +53.51% | Reiterates | 7 months ago |
Nucana PLCNCNA | 2 | Strong Buy | $150.00 | +3,806.25% | Reiterates | 8 months ago |
Fate Therapeutics IncFATE | 3 | Hold | $7.00 | +62.79% | Reiterates | 8 months ago |
Bioxcel Therapeutics IncBTAI | 4 | Strong Buy | $31.00 | +1,043.91% | Maintains | 8 months ago |
Uniqure NvQURE | 1 | Strong Buy | $55.00 | +1,106.14% | Maintains | a year ago |
Mei Pharma IncMEIP | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Instil Bio IncTIL | 2 | Strong Buy | $320.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 3 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Infinity Pharmaceuticals IncINFI | 2 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 3 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $32.00 | N/A | Downgrades | 3 years ago |
Athenex IncATNXQ | 1 | Hold | $120.00 | N/A | Downgrades | 3 years ago |
Opthea LtdOPT | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Therapeutics IncAPLT | 1 | Strong Buy | $85.00 | N/A | Initiates Coverage On | 4 years ago |
Celgene CorpCELG | 3 | Hold | $77.00 | N/A | Maintains | 5 years ago |
Alexion Pharmaceuticals IncALXN | 4 | Strong Buy | $190.00 | N/A | Maintains | 6 years ago |
Five Prime Therapeutics IncFPRX | 1 | Strong Buy | $44.00 | N/A | Maintains | 6 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $63.00 | N/A | Maintains | 6 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Kite Pharma IncKITE | 1 | Hold | $87.00 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.